Global Ganja Report

The networking group CannaGather held its fifth confab at lower Manhattan's Galvanize venue Sept. 28, bringing together some 200 entrepreneurs, investors, press and activists from throughout the New York metropolitan area. Inspired by the New York tech industry meet-ups of the dot-com boom in the late '90s, CannaGather hopes to similarly connect people in a burgeoning industry and help spur its growth.

Amid the legal ambiguities about the status of cannabidiol (CBD), authorities in one state that had cracked down on preparations of the salutary cannabinoid are now admitting that they themselves are confused. Weeks after Indiana State Excise Police declared products containing CBD oil to be illegal—and carrying out a raid on an Indianapolis-aread natural goods store to prove it—state officials say they don’t actually know if CBD oil products are illegal or not.

It has been a long, slow ride for patients hoping to get access to medical marijuana in the Lone Star state—and then just special strains of low-THC cannabis, and only for those suffering from "intractable epilepsy." Three dispensaries are hoping to get final approval from Texas authorities to start cultivating next month. Of course, it will be several more months before they can actually begin distributing—and then ambiguities in the law may mean further delays. Activists and lawmakers are pushing both to clear things up and expand the scope of the program.

Hemp Business Journal reports that products infused with CBD oil are leading growth in hermp-derived products sold in the United States generally, which in 2016 had a collective retail value of $688 million. This figure represents a five year 22% compound annual growth rate (CAGR). Joining more traditional products such as shelled seed, protein powder, soaps and lotions, are growing lines of medicinal preparations such as CBD edibles. Hemp-derived cannabidiol (CBD) accounted for $130 million in sales last year.

Three of the Balkan states to emerge from the ashes of Yugoslavia a generation ago are now among the first countries in the ex-communist world to move toward embrace of medical marijuana.

Oops, he did it again. Acting Drug Enforcement Administration chief Chuck Rosenberg reiterated his oft-voiced opinion on May 25 that "marijuana is not medicine." The Washington Examiner reports that he told an audience at a clinic in Cleveland: "If it turns out that there is something in smoked marijuana that helps people, that's awesome. I will be the last person to stand in the way of that... But let's run it through the Food and Drug Administration process, and let's stick to the science on it."

Florida is rapidly shaping up as a test case in whether the term "medical marijuana" necessarily has to include actual herbaceous cannabis. On May 15, the state's  Health Department ordered Quincy-based Trulieve dispensary to stop selling a "whole flower" product—officially intended for use in vaporizers but which can of course also be smoked. Trulieve just last week began sales of product dubbed “Entourage,”—named for the so-called "entourage effect," the synergistic workings of the various compounds in the actual cannabis flower. product meant to be used in the Volcano vaporizer, last week, reports Orlando Weekly. The Health Department's cease-and-desist letter came after local media reports about the sales of Entourage.

Mexico's lower-house Chamber of Deputies on April 28 approved a bill to allowing use, production and distribution of cannabis for medical and scientific purposes. The vote was an overwhelming 371 in favor and seven against with 11 abstentions. The legislation was already approved by the Mexican Senate in December and now goes to the desk of President Enrique Pena Nieto for his signature. The passage follows a national debate on the question in the media and various social forums across the country.